Article Sidebar

PDF (Tiếng Việt)
Published: 2021-06-21
Abstract Views: 333
Views PDF (Tiếng Việt): 183
DOI: https://doi.org/10.52163/yhc.v62i4%20(2021).101
Issue
Vol. 62 No. 4 (2021)
Section
Articles
How to Cite
Phu, L. M., Mai, D. V., Thai, H. D., & Tri, B. D. M. (2021). SITUATION USING CARBAPENEM. Vietnam Journal of Community Medicine, 62(4 (2021). https://doi.org/10.52163/yhc.v62i4 (2021).101

SITUATION USING CARBAPENEM

Le Minh Phu1, Do Van Mai, Hoang Duc Thai, Bui Dang Minh Tri
1 Tay Do University

Main Article Content

Abstract

Objective: To survey the use of carbapenem antibiotics at An Sinh General Hospital. Subjects and methods: retrospective descriptive study on 100 medical records of patients being treated in departments of An Sinh General Hospital from June 1st, 2020 to December 31st, 2020. Results: The carbapenem antibiotic used at An Sinh General Hospital mainly indicated for the treatment of pneumonia accounted for the highest percentage with 53.3%. There were 100% of strains of Haemophilus influenzae; Rhizobium radiobacter; Proteus. cp; Streptococcus mitis, which was also sensitive to carbapenem. 100% strains of Stenotrophomonas maltophilia bacteria was resistant to meropenem; 01 strain of Burkhorderia vietnamiensis was isolated against imipenem; 2 of 3 strains of Staphylococcus aereus isolated were resistant to meropenem. Carbapenem was mainly used in combination regimens. The proportion of the combination in the initial regimen was 100%. The rate of combination of 3 antibiotics was 22.7%. In the replaceable regimen, the combination rate was 82.2%. Conclusion: The carbapenem group was indicated for the treatment of pneumonia. Strains of the bacteria Haemophilus influenzae; Rhizobium radiobacter; Proteus. cp; Streptococcus mitis was also sensitive to carbapenem. Bacteria strains Stenotrophomonas maltophilia, Burkhorderia vietnamiensis and Staphylococcus aereus were resistant to meropenem. Carbapenem was mainly used in combination regimens.

Article Details

Keywords

The situation of usage of antibiotics and Carbapenem antibiotic

References

1. Chinh LH, Medical Microbiology, Hanoi Medical Publishing House, 2007. (in Vietnamese)
2. World Health Organization, WHO publishes list of bacteria for which new antibiotics are urgently needed, 2017.
3. David NG et al., The Sanford Guide To Antimicrobial Therapy, Antimicrobial Therapy, 2016:112-122.
4. Alexander EL, Loutit J, Tumbarello M et al., Carbapenem-Resistant Enterobacteriaceae Infections: Results From a Retrospective Series and Implications for the Design of Prospective Clinical Trials, Open Forum Infect Dis., 2017; 4(2): 63.
5. Quynh PT, Giap VV, Some clinical, subclinical, and hospital pneumonia features at Bach Mai Hospital Respiratory Center 2016-2017, Proceedings of the Vietnam Respiratory Association Annual Scientific Conference, 2017. (in Vietnamese)
6. Nghia ND, Anh NH, Study on clinical and subclinical characteristics and evaluation of hospital pneumonia treatment results caused by Pseudomonas aeruginosa at Bach Mai hospital from September 2016 to June 2017, Proceedings of the Vietnam Respiratory Society annual conference, 2017. (in Vietnamese)
7. Minh NTL, Evaluation of the use of carbapenem antibiotics at Bach Mai Hospital, Master Thesis, Hanoi University of Pharmacy, 2013. (in Vietnamese)